F22Maintenance hormonal therapy (MHT) in metastatic breast cancer (MBC) patients treated with first-line chemotherapy: retrospective analysis of the impact on progression-free survival (PFS) and overall survival (OS) in a “real life” setting
Garrone, O., Di Maio, M., Vandone, A.M., Brizio, R., Vanella, P., Miraglio, E., Comino, A., Merlano, M.C.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw337.22
Date:
September, 2016
File:
PDF, 63 KB
2016